The first-of-its-kind collaboration between the organisations is aimed at increasing industry-academia knowledge sharing in emerging technology areas
Wipro GE Healthcare, a leading global medical technology, diagnostics, and digital solutions innovator, signed a Memorandum of Understanding (MoU) with the Indian Institute of Science (IISc), for a pioneering alliance to advance healthcare innovation, research, and technology development in India. This collaboration aims to take a comprehensive approach to solving the care gap by addressing the full lifecycle that includes co-developing solutions, validating the technologies, and manufacturing them locally to bring them to the market. With the impending commencement of the Bagchi-Parthasarathy Hospital & IISc Medical School, this strategic collaboration will enable the translation of technologies from bench to bedside.
The collaboration will entail co-development initiatives in the areas of basic and applied science, systems engineering, product and software development, consultancy, publications, academic studies, internships, fellowships, and training. IISc and GE HealthCare will constitute a joint working committee, comprising representatives from both sides, for research around product and solution development.
Govindan Rangarajan, Director, IISc, said, “We see a tremendous need for innovative R&D that can improve outcomes in patients with NCD. The collaboration will emphasise combining science and engineering with translational & clinical research to epitomise “bench-to-bedside” innovation. GE HealthCare is the right partner for us in this initiative, given its leadership and strong footprint in India for R&D and manufacturing. We are confident that together, we can accelerate India’s position as a global force for healthcare for the world.”
Chaitanya Sarawate, MD, Wipro GE Healthcare and President & CEO, GE HealthCare South Asia, said, “This is a strategic collaboration that combines the strengths, capabilities, and local infrastructure of both entities. Our aim together is to invest in technologies of the future that can revolutionize the care paradigm – with more precise, connected, and compassionate care to patients in India and worldwide.”
The collaboration aligns with the Indian Government’s emphasis on fostering local Research and Development (R&D) and Manufacturing in the MedTech sector, necessitating Public-Private Partnership (PPP) models to further drive technology development. Collaborative efforts by both entities will be deployed for product development and clinical research, improving indigenisation of manufacturing and academic activities to strengthen the healthcare ecosystem.
